Apicore US LLC.

Please contact us by phone or email to discuss new business opportunities.

Product Search : FDP Form:   And/Or   Name/Keyword:
View all Products
Atomoxetine
Product FDP Form: Solid Oral
FDP Presentation: Capsule
Apicore API Status: R & D
Apicore API Market Status: Dev Qtys
DMF Status: R&D
Therapeautic category: Centrel Nervous System Agent
Dosage Form: Capsule
Route: oral
RLD: Strattera
Strengths: 10MG, 18MG, 25MG, 40MG, 60MG, 80MG, 100MG
Indication: Indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).
Go To Products